Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
β Scribed by Giorgio Sandrini; Armando Perrotta; Cristina Tassorelli; Paola Torelli; Filippo Brighina; Grazia Sances; Giuseppe Nappi
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 277 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1129-2369
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula
## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, doubleβblind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei